Stephen M. Stahl

Research interests

Publications

• Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

  World Psychiatry · 2023 · https://doi.org/10.1002/wps.21120

• Stahl's Essential Psychopharmacology

  Cambridge University Press eBooks · 2021 · 10.1017/9781108975292

• Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

  American Journal of Psychiatry · 2021 · https://doi.org/10.1176/appi.ajp.2020.20081251

• Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate

  CNS Spectrums · 2018 · 10.1017/s1092852918001013

• Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder

  CNS Spectrums · 2015 · 10.1017/s1092852914000832

• Serotonergic Drugs for Depression and Beyond

  Current Drug Targets · 2013 · 10.2174/1389450111314050007

• The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?

  Trends in Pharmacological Sciences · 2013 · 10.1016/j.tips.2013.04.001

• Agomelatine in the Treatment of Major Depressive Disorder

  The Journal of Clinical Psychiatry · 2010 · 10.4088/jcp.09m05471blu

• Multifunctional Pharmacology of Flibanserin: Possible Mechanism of Therapeutic Action in Hypoactive Sexual Desire Disorder

  The Journal of Sexual Medicine · 2010 · 10.1111/j.1743-6109.2010.02032.x

• Neuropsychopharmacology

  Journal · 2010 · https://doi.org/10.1007/978-3-540-68706-1_4410

• Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

  Acta Psychiatrica Scandinavica · 2009 · 10.1111/j.1600-0447.2008.01334.x

• Mechanism of Action of Trazodone:a Multifunctional Drug

  CNS Spectrums · 2009 · 10.1017/s1092852900024020

• Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications

  Journal · 2008

• Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation

  Trends in Pharmacological Sciences · 2007 · 10.1016/j.tips.2007.05.003

• The many faces of fatigue in major depressive disorder

  The International Journal of Neuropsychopharmacology · 2005 · 10.1017/s1461145704004729

• SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

  CNS Spectrums · 2005 · 10.1017/s1092852900019726

• A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

  The Primary Care Companion For CNS Disorders · 2004 · 10.4088/pcc.v06n0403

• Effectiveness of St John's wort in major depression: a randomized controlled trial.

  PubMed · 2001 · 10.1001/jama.285.15.1978

• Molecular Neurobiology for Practicing Psychiatrists, Part 5: How a Leucine Zipper Can Turn On Genes: Immediate-Early Genes Activate Late-Gene Expression in the Brain.

  The Journal of Clinical Psychiatry · 2000 · 10.4088/jcp.v61n0103

• The International Journal of Neuropsychopharmacology

  The International Journal of Neuropsychopharmacology · 1998 · 10.1017/s1461145798009018

• Mechanism of action of serotonin selective reuptake inhibitors

  Journal of Affective Disorders · 1998 · https://doi.org/10.1016/s0165-0327(98)00221-3

• Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.

  PubMed · 1998

• Essential Psychopharmacology: Neuroscientific Basis and Practical Applications

  Medical Entomology and Zoology · 1996

• The Human Platelet

  Archives of General Psychiatry · 1977 · 10.1001/archpsyc.1977.01770170019001

• The Dopamine Hypothesis of Schizophrenia: A Review*

  Schizophrenia Bulletin · 1976 · https://doi.org/10.1093/schbul/2.1.19

Current projects

No projects listed.